의료 권고사항

Archived 47: Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022: Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults

National Advisory Committee on Immunization예방접종2022보관된 문서

ASEM 문헌 요약

Official National Advisory Committee on Immunization document (2022) on “Archived 47: Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022: Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults”. Summary of NACI updates on the use of Moderna Spikevax BA.4/5 bivalent mRNA COVID-19 booster vaccine in adults.

이 요약은 문서를 식별하는 데 도움이 됩니다. 임상 권고사항은 항상 공식 버전과 업데이트 날짜를 확인하십시오.

공식 문서

관련 진료지침

Summary of the NACI Seasonal Influenza Vaccine Statement for 2025–2026 Summary of NACI statement of April 30, 2025: Statement on seasonal influenza vaccines for 2025–2026 Statement on seasonal influenza vaccines for 2025–2026